Clinical Outcomes and Safety of Upper Endoscopy While on Glucagon-Like Peptide-1 Receptor Agonists.
Journal
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775
Informations de publication
Date de publication:
03 Apr 2024
03 Apr 2024
Historique:
received:
10
01
2024
revised:
10
03
2024
accepted:
11
03
2024
pubmed:
5
4
2024
medline:
5
4
2024
entrez:
4
4
2024
Statut:
aheadofprint
Résumé
Glucose-like peptide-1-receptor agonists (GLP-1RAs) have become integral to the management of type 2 diabetes and obesity. GLP-1RAs work in part through delaying gastric emptying, raising concerns about retained gastric contents (RGC) during esophagogastroduodenoscopy (EGD).
Identifiants
pubmed: 38574832
pii: S1542-3565(24)00295-7
doi: 10.1016/j.cgh.2024.03.013
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Investigateurs
Roberto Simons-Linares
(R)
W Scott Butsch
(WS)
Informations de copyright
Copyright © 2024. Published by Elsevier Inc.